AREG and liver cancer: To determine whether NK cell‐derived AREG impairs NK cell anti‐tumor activity beyond skin cancers, we tested AREG KO NK cells in NCG mice engrafted with two NK cell‐sensitive liver cancer cell lines, HepG2 and Huh7.